Adtalem Global Education (NYSE:CVSA) Releases Quarterly Earnings Results, Beats Expectations By $0.29 EPS

Adtalem Global Education (NYSE:CVSA) announced its quarterly earnings data on Thursday. The company reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.29, FiscalAI reports. The company had revenue of $511.53 million for the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.

Adtalem Global Education Price Performance

Shares of CVSA stock traded up $2.27 during trading hours on Thursday, reaching $128.77. 371,577 shares of the company were exchanged, compared to its average volume of 275,687. Adtalem Global Education has a fifty-two week low of $86.97 and a fifty-two week high of $145.43. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. The stock’s fifty day moving average is $128.06 and its two-hundred day moving average is $122.06. The company has a market cap of $4.36 billion, a price-to-earnings ratio of 15.33, a P/E/G ratio of 0.94 and a beta of 0.65.

Insider Activity at Adtalem Global Education

In related news, CAO Manjunath Gangadharan sold 1,802 shares of the business’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $137.18, for a total value of $247,198.36. Following the completion of the transaction, the chief accounting officer owned 5,083 shares in the company, valued at $697,285.94. The trade was a 26.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Phelan sold 2,186 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.15, for a total value of $295,437.90. Following the completion of the transaction, the chief financial officer owned 48,306 shares in the company, valued at $6,528,555.90. The trade was a 4.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 20,365 shares of company stock worth $2,704,088. 2.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Adtalem Global Education

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new stake in Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company’s stock.

Wall Street Analyst Weigh In

CVSA has been the subject of a number of recent research reports. BMO Capital Markets cut their target price on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a research note on Monday, October 5th. Weiss Ratings raised shares of Adtalem Global Education from a “hold (c)” rating to a “hold (c+)” rating in a report on Wednesday, October 21st. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Sunday, September 27th. Finally, Truist Financial downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a research note on Thursday, September 3rd. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Adtalem Global Education presently has a consensus rating of “Hold” and an average price target of $151.67.

About Adtalem Global Education

Adtalem Global Education, Inc is an education services company that provides healthcare and professional education through institutions serving students in the United States and internationally. The company focuses on preparing students for careers in healthcare, including nursing, medicine, veterinary medicine and other health-related fields.

Its portfolio has included Chamberlain University, Walden University, the American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine.